Megan Mulcahy

Combination of pembrolizumab and pelareorep promotes anti-tumour immunity in advanced pancreatic adenocarcinoma (PDAC)

A. Benson, D. Mahalingam, I. Helenowski, 2023, British Journal of Cancer.